GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Pretax Margin %

DuoGenic StemCells (ROCO:7607) Pretax Margin % : -404.93% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. DuoGenic StemCells's Pre-Tax Income for the six months ended in Dec. 2024 was NT$-28.18 Mil. DuoGenic StemCells's Revenue for the six months ended in Dec. 2024 was NT$6.96 Mil. Therefore, DuoGenic StemCells's pretax margin for the quarter that ended in Dec. 2024 was -404.93%.

The historical rank and industry rank for DuoGenic StemCells's Pretax Margin % or its related term are showing as below:

ROCO:7607' s Pretax Margin % Range Over the Past 10 Years
Min: -994.56   Med: -501.44   Max: -329.77
Current: -511.26


ROCO:7607's Pretax Margin % is ranked worse than
67.94% of 995 companies
in the Biotechnology industry
Industry Median: -125.26 vs ROCO:7607: -511.26

DuoGenic StemCells Pretax Margin % Historical Data

The historical data trend for DuoGenic StemCells's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Pretax Margin % Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Pretax Margin %
-994.56 -491.61 -329.77 -511.26

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Pretax Margin % Get a 7-Day Free Trial -421.74 -303.46 -359.98 -656.60 -404.93

Competitive Comparison of DuoGenic StemCells's Pretax Margin %

For the Biotechnology subindustry, DuoGenic StemCells's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DuoGenic StemCells's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DuoGenic StemCells's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where DuoGenic StemCells's Pretax Margin % falls into.


;
;

DuoGenic StemCells Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

DuoGenic StemCells's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-61.617/12.052
=-511.26 %

DuoGenic StemCells's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-28.183/6.96
=-404.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DuoGenic StemCells  (ROCO:7607) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


DuoGenic StemCells Pretax Margin % Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


DuoGenic StemCells Business Description

Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines